Radiation therapy for ductal carcinoma in situ: A decision analysis

Cancer

Volumn 118, Issue 3, 2012, Pages 603-611

  Punglia, Rinaa S ^a   Burstein, Harold J ^a   Weeks, Jane C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

breast cancer; decision analysis; ductal carcinoma in situ; radiation therapy

Indexed keywords

AGE; ARTICLE; BREAST SURGERY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; INTRADUCTAL CARCINOMA; MASTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; RECURRENCE RISK; SIMULATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMBINED MODALITY THERAPY; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MARKOV CHAINS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84856212021     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26293     Document Type: Article

References (30)

1. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002; 94: 1546-1554.
2. Baxter NN, Virnig BA, Durham SB, Tuttle TM,. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004; 96: 443-448.
3. Sumner WE 3rd, Koniaris LG, Snell SE, et al. Results of 23,810 cases of ductal carcinoma-in-situ. Ann Surg Oncol. 2007; 14: 1638-1643.
4. American Cancer Society. Cancer Facts and Figures 2008. Atlanta, GA: American Cancer Society; 2008.
5. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006; 24: 3381-3387.
6. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N,. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol. 2001; 28: 400-418.
7. Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol. 2006; 45: 536-543.
8. Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M,. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet. 2003; 362: 95-102.
9. Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol. 2010; 361 (S1470-S2045): 70266-70267.
10. Gilleard O, Goodman A, Cooper M, Davies M, Dunn J,. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ [serial online]. World J Surg Oncol. 2008; 6: 61.
11. Silverstein MJ,. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 2003; 186: 337-343.
12. Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006; 24: 1031-1036.
13. MacAusland SG, Hepel JT, Chong FK, et al. An attempt to independently verify the utility of the Van Nuys prognostic index for ductal carcinoma in situ. Cancer. 2007; 110: 2648-2653.
14. Smith BD, Haffty BG, Buchholz TA, et al. Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst. 2006; 98: 1302-1310.
15. Rakovitch E, Pignol JP, Chartier C, et al. The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Breast Cancer Res Treat. 2007; 101: 335-347.
16. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: National Academies Press; 2009.
17. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087-2106.
18. Sonnenberg FA, Beck JR,. Markov models in medical decision making: a practical guide. Med Decis Making. 1993; 13: 322-338.
19. National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Program. Accessed April 2, 2009.
20. Olivotto IA, Truong PT, Speers CH,. Staging reclassification affects breast cancer survival. J Clin Oncol. 2003; 21: 4467-4468.
21. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999; 353: 1993-2000.
22. Arias E,. United States life tables, 2004. Natl Vital Stat Rep. 2007; 56: 1-39.
23. Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010; 41: 162-177.
24. Hillner BE, Desch CE, Carlson RW, Smith TJ, Esserman L, Bear HD,. Trade-offs between survival and breast preservation for 3 initial treatments of ductal carcinoma-in-situ of the breast. J Clin Oncol. 1996; 14: 70-77.
25. Schrag D, Kuntz KM, Garber JE, Weeks JC,. Decision analysis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997; 336: 1465-1471.
26. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998; 16: 441-452.
27. Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM,. Results of wide excision for mammary recurrence after breast-conserving therapy. Cancer. 1988; 61: 1969-1972.
28. Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG,. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys. 2005; 63: 845-851.
29. Kerlikowske K, Molinaro AM, Gauthier ML, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010; 102: 627-637.
30. Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010; 28: 3762-3769.